M M Claassens
Overview
Explore the profile of M M Claassens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engel N, Apolosi I, Bhargava A, Bhan A, Celan C, Mak A, et al.
Int J Tuberc Lung Dis
. 2024 Oct;
28(11):517-520.
PMID: 39468025
Reducing systemic inequities in testing, access to care, social protection - and in the scientific process - is essential to end TB. Incorporating social science methods and expertise on inequity...
2.
Kweza P, Van Schalkwyk C, Abraham N, Uys M, Claassens M, Medina-Marino A
Int J Tuberc Lung Dis
. 2018 Feb;
22(3):264-272.
PMID: 29471903
Setting: The present study was conducted at 20 randomly selected primary health clinics across Buffalo City Metropolitan Health District, a high TB burden district in South Africa. Objective: To estimate...
3.
Van Wyk S, Lin H, Claassens M
Int J Tuberc Lung Dis
. 2017 Mar;
21(4):405-411.
PMID: 28284255
A systematic review was conducted to describe the quality and characteristics of prediction models for prevalent pulmonary tuberculosis (PTB) in adults at routine TB care settings. A prediction model was...
4.
Dreyer A, Mbambo D, Machaba M, Oliphant C, Claassens M
BMC Health Serv Res
. 2017 Mar;
17(1):190.
PMID: 28283037
Background: Tuberculosis control programs rely on accurate collection of routine surveillance data to inform program decisions including resource allocation and specific interventions. The electronic TB register (ETR.Net) is dependent on...
5.
Claassens M, Van Schalkwyk C, Floyd S, Ayles H, Beyers N
PLoS One
. 2017 Mar;
12(3):e0172881.
PMID: 28257424
Background: High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks,...
6.
Claassens M, Dunbar R, Yang B, Lombard C
Int J Tuberc Lung Dis
. 2017 Feb;
21(2):196-201.
PMID: 28234084
Background: Smear-positive patients should be started on anti-tuberculosis treatment promptly. However, studies show that up to 38% of diagnosed patients are initial loss to follow-up (LTFU), meaning they do not...
7.
Elliott E, Draper H, Baitsiwe P, Claassens M
Public Health Action
. 2015 Sep;
4(3):201-3.
PMID: 26400811
The Northern Cape Province has low cure rates (21%) for multidrug-resistant tuberculosis (TB). We audited the programme to identify factors affecting treatment outcomes. Cases admitted to two drug-resistant TB units...
8.
Ledibane T, Motlhanke S, Rose A, Kruger W, Ledibane N, Claassens M
Public Health Action
. 2015 Sep;
5(2):112-5.
PMID: 26400380
Background: South Africa has the second worst tuberculosis-human immunodeficiency virus (TB-HIV) syndemic in the world: in 2011, the TB-HIV co-infection rate was estimated at 65%. Integration of TB and HIV...
9.
Claassens M, Jacobs E, Cyster E, Jennings K, James A, Dunbar R, et al.
Int J Tuberc Lung Dis
. 2013 Apr;
17(5):608-14.
PMID: 23575325
Setting: This study was conducted in Cape Town in two primary health care facilities in a sub-district with a high prevalence of bacteriologically confirmed pulmonary tuberculosis (TB). Objective: To determine...
10.
Claassens M, Du Toit E, Dunbar R, Lombard C, Enarson D, Beyers N, et al.
Int J Tuberc Lung Dis
. 2013 Apr;
17(5):603-7.
PMID: 23575324
Setting: Primary health care facilities in five provinces of South Africa. Objective: To investigate the association between the proportion of sputum results with a prolonged smear turnaround time and the...